Clinical Trial Update: Busulfan, Melphalan, Escalating Carfilzomib Conditioning Auto Stem Cell Transplantation for Multiple Myeloma (MM) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial exploring busulfan, melphalan, and escalating carfilzomib conditioning for autologous stem cell transplantation in multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• BUSULFAN (Busulfan)
• Carfilzomib (carfilzomib)
• Melphalan (Melphalan)

Snippet

Sponsor: Loyola University | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: UNKNOWN